Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Effects of 2-Chlorodeoxyadenosine (Cladribine) on Primary Rat Microglia.
Biogen Third Quarter 2015 Revenues Increase 11% to $2.8 Billion; Company Raises 2015 Full Year Guidance
Prevalence of neurological disorders in Al Quseir, Egypt: methodological aspects.
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
Genzyme’s once-daily, oral AUBAGIO® approved in Australia for treatment of relapsing multiple sclerosis
Launch of a phase 3 clinical trial in the treatment of Alzheimer’s disease with masitinib
Society for Neuroscience Annual Meeting
The scales and tales of myelination: using zebrafish and mouse to study myelinating glia.
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Raxone®/Catena® (idebenone)
Impact of cladribine therapy on changes in circulating dendritic cell subsets, T cells and B cells in patients with multiple sclerosis.
UCSF Seminar: "Dynamics of Retina Damage in Acute Optic Neuritis"
Comparison of the Effects of Matrix Metalloproteinase Inhibitors on TNF-α Release from Activated Microglia and TNF-α Converting Enzyme Activity.
3 Blockbuster Drugs Losing Patent Protection in 2013's Final Months
Mechanism-based CNS Disease Modeling: Applications in Neurology and Psychiatry Drug Research & Development
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
Interferon β-1b directly modulates human neural stem/progenitor cell fate.
Glatiramer Acetate administration does not reduce damage after cerebral ischemia in mice.
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
Neuromyelitis optica: Evaluation of 871 attacks and 1153 treatment courses.
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine.
Multiple Sclerosis and Pregnancy: Current Considerations.
New Drugs Online report for idebenone
Pages
« first
‹ previous
…
102
103
104
105
106
107
108
109
110
…
next ›
last »